M-CSF: a novel plasmacytoid and conventional dendritic cell poietin

被引:83
|
作者
Fancke, Ben [1 ]
Suter, Mark [1 ,2 ]
Hochrein, Hubertus [1 ]
O'Keeffe, Meredith [1 ]
机构
[1] Bavarian Nordic, Dept Res, D-82152 Martinsried, Germany
[2] Univ Zurich, Inst Virol, Zurich, Switzerland
关键词
D O I
10.1182/blood-2007-05-089292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The critical importance of plasmacytoid dendritic cells (pDCs) in viral infection, autoimmunity, and tolerance has focused major attention on these cells that are rare in blood and immune organs of humans and mice. The recent development of an Flt-3 ligand (FL) culture system of bone marrow cells has led to the simple generation of large numbers of pDCs that resemble their in vivo steady-state counterparts. The FL system has allowed unforeseen insight into the biology of pDCs, and it is assumed that FL is the crucial growth factor for these cells. Surprisingly we have found that a cell type with high capacity for interferon-alpha (IFN-alpha) production in response to CpG-containing oligonucleotides, a feature of pDCs, develop within macrophage-colony-stimulating factor (M-CSF)-generated bone marrow cultures. Analysis of this phenomenon revealed that M-CSIF is able to drive pDCs as well as conventional DCs (cDCs) from BM precursor cells in vitro. Furthermore, application of M-CSF to mice was able to drive pDCs and cDCs development in vivo. It is noteworthy that using mice deficient in FL indicated that the M-CSF-driven generation of pDCs and cDCs in vitro and in vivo was independent of endogenous FL.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 50 条
  • [31] Multiple roles of M-CSF in human osteoclastogenesis
    Hodge, Jason M.
    Kirkland, Mark A.
    Nicholson, Geoffrey C.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (03) : 759 - 768
  • [32] Biological activities and clinical application of M-CSF
    Motoyoshi, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 67 (02) : 109 - 122
  • [33] Early events in M-CSF receptor signaling
    Bourette, RP
    Rohrschneider, LR
    GROWTH FACTORS, 2000, 17 (03) : 155 - 166
  • [34] PRODUCTION OF M-CSF BY HUMAN AND MURINE KERATINOCYTES
    CHODAKEWITZ, JA
    LACY, J
    BIRCHALL, N
    COLEMAN, DL
    CLINICAL RESEARCH, 1989, 37 (02): : A407 - A407
  • [35] HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities
    Suzu, S
    Harada, H
    Matsumoto, T
    Okada, S
    BLOOD, 2005, 105 (08) : 3230 - 3237
  • [36] The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF
    Campbell, IK
    Rich, MJ
    Bischof, RJ
    Hamilton, JA
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 68 (01) : 144 - 150
  • [37] Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy
    Azad, Farhan
    Zhang, Jiahua
    Miranda, Clive J.
    Gravina, Matthew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [38] Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow
    Nobuyuki Onai
    Aya Obata-Onai
    Michael A Schmid
    Toshiaki Ohteki
    David Jarrossay
    Markus G Manz
    Nature Immunology, 2007, 8 : 1207 - 1216
  • [39] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Minas P. Economides
    David Rizzieri
    Naveen Pemmaraju
    Current Hematologic Malignancy Reports, 2019, 14 : 515 - 522
  • [40] GM-CSF cannot substitute for M-CSF in human osteoclastogenesis
    Hodge, JM
    Kirkland, MA
    Nicholson, GC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 7 - 12